Spero Therapeutics, Inc. (SRTS) operates in its industry, focusing on biopharmaceutical development. The company demonstrates strong financial compliance with low debt levels and minimal non-compliant income, requiring only minor purification. Business activities appear permissible, with no major controversies or non-compliant segments identified. Inclusion in all major Shariah indices confirms overall compliance, making it a viable option for ethical investors.